| In millions, except per share items | Nov-30-19 | Nov-30-18 | Nov-30-17 | Nov-30-16 | Nov-30-15 | Nov-30-14 | Nov-30-13 | Nov-30-12 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Specialty Solutions | 513.0 | 487.6 | 441.4 | 404.3 | 419.9 | | | |
| Facility Closing | 223.2 | 282.2 | 341.7 | 355.6 | 418.1 | | | |
| Performance Chemicals | | | | | | 746.5 | 773.0 | 864.5 |
| Other | | | | | | 240.9 | 245.1 | 261.0 |
| Total revenues [+] | 736.2 | 769.8 | 783.1 | 759.9 | 838.0 | 987.4 | 1,018.1 | 1,125.5 |
| Products | 736.2 | 769.8 | 783.1 | | | | | |
| Revenue growth [+] | -4.4% | -1.7% | 3.1% | -9.3% | -15.1% | -3.0% | -9.5% | -6.3% |
| Specialty Solutions | 5.2% | 10.5% | 9.2% | -3.7% | | | | |
| Facility Closing | -20.9% | -17.4% | -3.9% | -14.9% | | | | |
| Performance Chemicals | | | | | | -3.4% | -10.6% | -9.2% |
| Engineered Surfaces | | | | | | -1.6% | -6.1% | 4.7% |
| Cost of goods sold | 560.0 | 579.1 | 582.3 | 556.0 | 644.1 | 788.0 | 805.4 | 898.3 |
| Gross profit | 176.2 | 190.7 | 200.8 | 203.9 | 193.9 | 199.4 | 212.7 | 227.2 |
| Gross margin | 23.9% | 24.8% | 25.6% | 26.8% | 23.1% | 20.2% | 20.9% | 20.2% |
| Selling, general and administrative | 109.7 | 106.2 | 118.6 | 118.5 | 119.3 | 120.2 | 118.1 | 121.2 |
| Equity in earnings | | | | | | | | |
| Other operating expenses | 20.3 | 1.9 | -0.5 | -0.7 | 11.0 | -3.4 | -1.3 | -1.4 |
| EBITDA [+] | 46.2 | 82.6 | 82.7 | 86.1 | 63.6 | 82.6 | 95.9 | 107.4 |
| EBITDA growth | -44.1% | -0.1% | -3.9% | 35.4% | -23.0% | -13.9% | -10.7% | -3.1% |
| EBITDA margin | 6.3% | 10.7% | 10.6% | 11.3% | 7.6% | 8.4% | 9.4% | 9.5% |
| Depreciation | 26.9 | 26.4 | 24.4 | 26.8 | 30.3 | 29.5 | 28.0 | 26.0 |
| EBITA | 19.3 | 56.2 | 58.3 | 59.3 | 33.3 | 53.1 | 67.9 | 81.4 |
| EBITA margin | 2.6% | 7.3% | 7.4% | 7.8% | 4.0% | 5.4% | 6.7% | 7.2% |
| Amortization of intangibles | 4.4 | 3.8 | 3.5 | 3.8 | 3.7 | 5.3 | 5.6 | 6.0 |
| EBIT [+] | 14.9 | 52.4 | 54.8 | 55.5 | 29.6 | 47.8 | 62.3 | 75.4 |
| EBIT growth | -71.6% | -4.4% | -1.3% | 87.5% | -38.1% | -23.3% | -17.4% | -2.5% |
| EBIT margin | 2.0% | 6.8% | 7.0% | 7.3% | 3.5% | 4.8% | 6.1% | 6.7% |
| Non-recurring items [+] | 15.2 | 19.3 | 39.7 | 18.0 | 25.9 | 1.4 | 2.4 | 2.0 |
| Asset impairment | 7.8 | 13.5 | 32.9 | 5.7 | 19.4 | | 0.2 | 1.0 |
| Loss (gain) on sale of assets | -4.0 | -0.9 | 0.4 | 0.3 | 0.2 | 0.5 | -4.9 | |
| Interest expense, net [+] | 18.5 | 17.8 | 19.2 | 24.7 | 28.3 | 32.1 | 31.9 | 36.5 |
| Interest expense | 18.5 | 17.8 | 19.2 | 24.7 | 28.3 | 32.9 | 31.9 | 36.5 |
| Interest income | | | | | | 0.8 | | |
| Other income (expense), net [+] | -0.2 | -0.8 | | -2.9 | 3.5 | -2.6 | -1.5 | |
| Gain (loss) on debt retirement | 0.2 | 0.8 | | 2.9 | 0.6 | 0.8 | 1.5 | |
| Write-off of deferred debt issuance costs | 0.2 | 0.8 | | 2.9 | 0.6 | 0.8 | 1.5 | |
| Other | | | | | -4.1 | -1.0 | 1.3 | -1.4 |
| Pre-tax income | -19.0 | 14.5 | -4.1 | 9.9 | -21.1 | 11.7 | 26.5 | 36.9 |
| Income taxes | 3.4 | -6.2 | 83.7 | 10.3 | -2.4 | -0.4 | 6.0 | 11.2 |
| Tax rate | | | | 104.0% | 11.4% | | 22.6% | 30.4% |
| Earnings from continuing ops | -22.4 | 20.7 | -87.8 | -0.4 | -18.7 | 12.1 | 20.5 | 25.7 |
| Earnings from discontinued ops | | | | | | | | 7.9 |
| Net income | -22.4 | 20.7 | -87.8 | -0.4 | -17.8 | 11.5 | 19.6 | 27.6 |
| Net margin | -3.0% | 2.7% | -11.2% | -0.1% | -2.1% | 1.2% | 1.9% | 2.5% |
| |
| Basic EPS [+] | ($0.50) | $0.46 | ($1.98) | ($0.01) | ($0.41) | $0.26 | $0.44 | $0.56 |
| Growth | -207.7% | -123.5% | 21652.3% | -97.8% | -258.0% | -41.2% | -21.1% | 51.2% |
| Diluted EPS [+] | ($0.50) | $0.46 | ($1.98) | ($0.01) | ($0.41) | $0.26 | $0.44 | $0.56 |
| Growth | -208.5% | -123.3% | 21652.3% | -97.8% | -259.3% | -41.6% | -21.3% | 51.2% |
| |
| |
| Shares outstanding (basic) [+] | 44.8 | 44.6 | 44.4 | 44.0 | 45.3 | 46.3 | 46.1 | 45.6 |
| Growth | 0.4% | 0.5% | 0.9% | -2.9% | -2.2% | 0.4% | 1.1% | 1.8% |
| Shares outstanding (diluted) [+] | 44.8 | 44.9 | 44.4 | 44.0 | 45.7 | 47.1 | 46.6 | 46.0 |
| Growth | -0.2% | 1.1% | 0.9% | -3.7% | -3.0% | 1.1% | 1.3% | 1.8% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |